United States · 
Who invested in Eclipse Regenesis?
Eclipse Regenesis's investors include National Institutes of Health and Small Business Innovation Research.
United States · Venture startup
Who invested in Eclipse Regenesis
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2022, from 1 source
- Latest round
- VentureAug 2022
- Investors
- 2
The rounds
- Aug 2022VentureAmount undisclosed
Source recorded
Founders and team
From Eclipse Regenesis's own website: 1 founder, 4 on the team.
- Andrew LantzHead of Design
- Greg FungHead of Operations
- Ryan HelmuthHead of Therapy Development
- Michael SeffrenSenior R&D Engineer
AdvisersProudly Partnered
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 3 firms list Eclipse Regenesis as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Eclipse Regenesis
How much has Eclipse Regenesis raised?
Eclipse Regenesis has raised 1 round since 2022, none with a disclosed amount.
When did Eclipse Regenesis last raise?
Eclipse Regenesis's most recent round was a Venture in Aug 2022.
Who backed Eclipse Regenesis first?
Eclipse Regenesis's first round on record, in Aug 2022, was backed by National Institutes of Health and Small Business Innovation Research.
What stage is Eclipse Regenesis at?
Eclipse Regenesis's latest named round is a Venture, in Aug 2022.
Where is Eclipse Regenesis based?
Eclipse Regenesis is based in the United States.
Companies like Eclipse Regenesis
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.